NR3C2 and acute kidney injury: There was less frequent dispensing of thiazides (sHR, 0.93; 95% CI, 0.89–0.98) and dihydropyridine calcium channel blockers (sHR, 0.89; 95% CI, 0.83–0.95) in patients with AKI and more frequent dispensing of loop diuretics (sHR, 1.20; 95% CI, 1.17–1.23) and mineralocorticoid receptor antagonists (sHR, 1.22; 95% CI, 1.15–1.28).